570 related articles for article (PubMed ID: 28458541)
1. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
[TBL] [Abstract][Full Text] [Related]
2. Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models.
Lugert S; Unterweger H; Mühlberger M; Janko C; Draack S; Ludwig F; Eberbeck D; Alexiou C; Friedrich RP
Int J Nanomedicine; 2019; 14():161-180. PubMed ID: 30613144
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods.
Friedrich RP; Janko C; Poettler M; Tripal P; Zaloga J; Cicha I; Dürr S; Nowak J; Odenbach S; Slabu I; Liebl M; Trahms L; Stapf M; Hilger I; Lyer S; Alexiou C
Int J Nanomedicine; 2015; 10():4185-201. PubMed ID: 26170658
[TBL] [Abstract][Full Text] [Related]
4. Cellular SPION Uptake and Toxicity in Various Head and Neck Cancer Cell Lines.
Balk M; Haus T; Band J; Unterweger H; Schreiber E; Friedrich RP; Alexiou C; Gostian AO
Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33805818
[TBL] [Abstract][Full Text] [Related]
5. Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility.
Zaloga J; Janko C; Nowak J; Matuszak J; Knaup S; Eberbeck D; Tietze R; Unterweger H; Friedrich RP; Duerr S; Heimke-Brinck R; Baum E; Cicha I; Dörje F; Odenbach S; Lyer S; Lee G; Alexiou C
Int J Nanomedicine; 2014; 9():4847-66. PubMed ID: 25364244
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Serum Proteins and Surface Chemistry on Magnetic Nanoparticle Colloidal Stability and Cellular Uptake in Breast Cancer Cells.
Mekseriwattana W; Srisuk S; Kriangsaksri R; Niamsiri N; Prapainop K
AAPS PharmSciTech; 2019 Jan; 20(2):55. PubMed ID: 30618013
[TBL] [Abstract][Full Text] [Related]
7. Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles.
Zaloga J; Feoktystov A; Garamus VM; Karawacka W; Ioffe A; Brückel T; Tietze R; Alexiou C; Lyer S
Colloids Surf B Biointerfaces; 2018 Jan; 161():18-26. PubMed ID: 29035747
[TBL] [Abstract][Full Text] [Related]
8. Tangential Flow Ultrafiltration Allows Purification and Concentration of Lauric Acid-/Albumin-Coated Particles for Improved Magnetic Treatment.
Zaloga J; Stapf M; Nowak J; Pöttler M; Friedrich RP; Tietze R; Lyer S; Lee G; Odenbach S; Hilger I; Alexiou C
Int J Mol Sci; 2015 Aug; 16(8):19291-307. PubMed ID: 26287178
[TBL] [Abstract][Full Text] [Related]
9. Shell matters: Magnetic targeting of SPIONs and in vitro effects on endothelial and monocytic cell function.
Matuszak J; Dörfler P; Zaloga J; Unterweger H; Lyer S; Dietel B; Alexiou C; Cicha I
Clin Hemorheol Microcirc; 2015; 61(2):259-77. PubMed ID: 26410877
[TBL] [Abstract][Full Text] [Related]
10. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
11. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.
Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M
Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004
[TBL] [Abstract][Full Text] [Related]
12. Investigation of Specific Targeting of Triptorelin-Conjugated Dextran-Coated Magnetite Nanoparticles as a Targeted Probe in GnRH
Yousefvand M; Mohammadi Z; Ghorbani F; Irajirad R; Abedi H; Seyedi S; Papi A; Montazerabadi A
Contrast Media Mol Imaging; 2021; 2021():5534848. PubMed ID: 34104122
[TBL] [Abstract][Full Text] [Related]
13. Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells.
Lindemann A; Lüdtke-Buzug K; Fräderich BM; Gräfe K; Pries R; Wollenberg B
Int J Nanomedicine; 2014; 9():5025-40. PubMed ID: 25378928
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and in vitro evaluation of exquisite targeting SPIONs-PEG-HER in HER2+ human breast cancer cells.
Almaki JH; Nasiri R; Idris A; Majid FA; Salouti M; Wong TS; Dabagh S; Marvibaigi M; Amini N
Nanotechnology; 2016 Mar; 27(10):105601. PubMed ID: 26861770
[TBL] [Abstract][Full Text] [Related]
15. Superparamagnetic iron-oxide nanoparticles mPEG350- and mPEG2000-coated: cell uptake and biocompatibility evaluation.
Silva AH; Lima E; Mansilla MV; Zysler RD; Troiani H; Pisciotti MLM; Locatelli C; Benech JC; Oddone N; Zoldan VC; Winter E; Pasa AA; Creczynski-Pasa TB
Nanomedicine; 2016 May; 12(4):909-919. PubMed ID: 26767515
[TBL] [Abstract][Full Text] [Related]
16. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).
Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G
Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy.
Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY
Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205
[TBL] [Abstract][Full Text] [Related]
18. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible and fluorescent superparamagnetic iron oxide nanoparticles with superior magnetic properties coated with charged polysaccharide derivatives.
Lachowicz D; Szpak A; Malek-Zietek KE; Kepczynski M; Muller RN; Laurent S; Nowakowska M; Zapotoczny S
Colloids Surf B Biointerfaces; 2017 Feb; 150():402-407. PubMed ID: 27842931
[TBL] [Abstract][Full Text] [Related]
20. Hypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapy.
Unterweger H; Subatzus D; Tietze R; Janko C; Poettler M; Stiegelschmitt A; Schuster M; Maake C; Boccaccini AR; Alexiou C
Int J Nanomedicine; 2015; 10():6985-96. PubMed ID: 26648714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
